Navigation Links
CPhI India and Co-Located Events Offer Diverse Programme to Support the Growing Indian Pharma Market
Date:10/18/2011

AMSTERDAM, Oct. 18, 2011 /PRNewswire/ -- Leading events organiser UBM Live, a division of UBM Plc (LSE: UBM), today announced details of CPhI India and its co-located events, which will be hosted from 30th November to 2nd December, 2011 at the Bombay Exhibition Centre in Mumbai, India. Focused on pharmaceutical ingredients, CPhI India will be joined by co-located events: P-MEC India for pharmaceutical equipment, machinery and technology; ICSE India for contract services, clinical trials; and CRO and the BioPh trail for the biopharma market. Catering to all sectors in the pharma industry, both domestic and international, UBM Live's cluster of India-focused events offer attendees a dedicated platform to network with key decision makers in the Indian pharmaceutical industry, connect with existing  partners and make new contacts. In 2010 the events hosted over 26,400 visitors and over 800 exhibiting companies, figures that UBM Live expects to be exceed this year.

Continuing UBM Live's commitment to developing and evolving value-add initiatives for visitors and exhibitors around its Indian events, the CPhI India Conference Series will return in 2011. Introduced in 2010 to positive feedback, the series programme will cover a selection of key trends and topics pertinent to the Indian and South Asian pharmaceuticals markets, including: Global Clinical Trials; Global Biosimilars Regulations; Healthcare and OTC Drugs; Developing Difficult Generics; Export Potential; and Competitive API Strategies.  The conference series will feature high level speakers from respected companies such as Sanofi-Aventis, GlaxoSmithKline, Pfizer, and Dr. Reddy's Laboratories.

"Mirroring the increasing importance of the Indian pharmaceutical market, CPhI India and co-located events have been built around a unique programme based on consultation and feedback from visitors and exhibitors," commented Annemieke Timmers, Brand Director C
'/>"/>

SOURCE UBM Live
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
2. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
3. Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
4. ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India
5. International Diabetes Federation Grant Supports Lifestyle Intervention Study to Prevent Type 2 Diabetes in India
6. Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks
7. Patient Recruitment Begins in India for Phase 3 Diabetes Trial
8. Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis
9. Life Sciences Company Opens Clinical Trial Bridge to India
10. Pioneering Brain Malformation Treatment Performed Using Novalis Tx(TM) Radiosurgery Technology in India
11. Reportlinker Adds Medical Devices & Equipment in India (2009)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015  BioDelivery Sciences ... the primary efficacy endpoint in the Phase 3 ... placebo for the treatment of painful diabetic neuropathy ... endpoints showed statistically significant improvement over placebo.  In ... was observed.  The results of this trial provide ...
(Date:3/29/2015)... TITUSVILLE, N.J. , March 29, 2015 /PRNewswire/ ... delayed time to relapse compared to placebo in ... 3 clinical study published this week in the ... (JAMA) Psychiatry . Results of ... recent New Drug Application (NDA) filing for three-month ...
(Date:3/27/2015)... /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") ... the issuance of an aggregate of 30,000 stock options ... aggregate of 120,500 stock options to employees and consultants ... three years and will be exercisable for a period ... per stock option. About Covalon Covalon ...
Breaking Medicine Technology:BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 2BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 3BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 4BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 2New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 4New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 6New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 7New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 8New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 9New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 10New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 11New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 12Covalon Announces Issuance of Stock Options 2
... Sequella, Inc., a clinical-stage biopharmaceutical company focused on ... announced that it received a $694,000 grant supplement as ... of 2009. The ARRA funds, issued through the National ... National Institute of Health (NIH), will assist Sequella to ...
... Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical ... ) focused on bringing the life saving potential ... nationwide and internationally, said today that it has retired ... of $212,959, $250,000 and $285,000. , On October 2, ...
Cached Medicine Technology:Sequella Receives American Recovery and Reinvestment Funding Through the NIH 2Cord Blood America Continues to Reduce Debt; Three Notes Retired 2
(Date:3/30/2015)... V/NO (Virtually No Alcohol) Wines have a ... opening/closing and for reuse. Consumers simply twist the cup, turn ... Yorkers, professionals, and basically anyone can now enjoy a ... back socially or pair with meals at work, home, or ... wine and that means Napa Wine grapes undergo the ...
(Date:3/30/2015)... 30, 2015 South Coast Surety is pleased ... Bond Representative. Richard has been known to the management of ... Richard attended the University of Georgia, majoring in Banking and ... the sales and sales management of business equipment for a ... Most recently, Richard was a senior officer with a National ...
(Date:3/30/2015)... 30, 2015 Considered to be the ... in the global business community, this next generation of ... ante by managing big data and frameworks with virtually ... already powerful analytic and logic features are a technological ... of Lazarus Alliance said “The IT Audit Machine is ...
(Date:3/30/2015)... GREEN, Ohio (PRWEB) March 30, 2015 ... a globally recognized designer and manufacturer of ... and vinyl upholstery options. The new upholsteries ... laboratory, education and custom seating, providing disinfectable, ... are manufactured by renowned textile purveyor CF ...
(Date:3/29/2015)... 2015 Pro Ace Care Heating & ... now provide qualified HVAC technicians that will visit the ... and related systems throughout Vancouver, North Vancouver, Burnaby, Richmond, ... conditioners, heat pumps require regular maintenance from a professional. ... BC Hydro strongly suggest you have it serviced annually ...
Breaking Medicine News(10 mins):Health News:Napa Valley Alcohol-Removed Red, White & Rosé Wines Have Launched. 2Health News:Richard Ford Joins South Coast Surety Contract Surety Team 2Health News:Building on Success: Next Generation of Cyber Crime Prevention Unveiled! 2Health News:BioFit Adds Bleachable Upholstery Options to Seating Line 2Health News:Pro Ace Care Now Provides Qualified HVAC Technicians for Heat Pump Maintenance 2
... , , Mr. Randall Terry and ... city tour, where they held press conferences, performed street theatre, and ... HR 3200. More Details and links at www.OverturnRoe.com , , ... by Randall Terry, founder of Operation Rescue. , , ...
... WASHINGTON, Aug. 26 Loretta King, Acting Assistant Attorney General ... a federal grand jury in Denver has charged Donald Hertz ... the Freedom of Access to Clinic Entrances (FACE) Act for ... The FACE Act makes it a federal crime to injure, ...
... gut noted in study of people with type 1 version ... abnormal immune response to wheat proteins may contribute to type ... people with type 1 diabetes found that nearly half had ... identified genes associated with this abnormal immune response. , "The ...
... genes that may contribute to drug resistance in non-small ... in the open access journal BMC Cancer ... in drug sensitivity and resistance and actual in vitro ... UK, led a team of researchers who assessed the ...
... ... Association (DIA), in cooperation with FDA and PhRMA, will host Progression-Free Survival Oncology Workshop ... ... Drug Information Association (DIA), in cooperation with FDA and PhRMA, will host ...
... , INDIANAPOLIS, Aug. 26 ... gaming interests reported more than $3.6 million in lobbying expenditures ... Indiana public records. , , Individuals employed ... giving more than $228,000 to state political party committees and ...
Cached Medicine News:Health News:Randall Terry, Abortion, and Health Care: Terry comments on disruption of 'Health Care' Town Hall meeting. 'Yes: We disrupted Howard Dean's speech, and we would do it again. Obama and Pelosi must write into the bill: "No Abortion Funding; No mandates for 2Health News:DIA/FDA/PhRMA to Host Progression-Free Survival Oncology Workshop 2Health News:DIA/FDA/PhRMA to Host Progression-Free Survival Oncology Workshop 3Health News:The Gaming Industry Stacks the Deck Against Smokefree Workplaces in Indiana 2
Implex cemented hip stem....
Stability cemented stem....
Porous foundation 440 series....
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Medicine Products: